Vince
Super Moderator
DALLAS, TX — The prevalence and severity of coronary artery calcium (CAC) after 14 years of metformin therapy were significantly lower in men, but not women, who started on the drug for prediabetes, in a longitudinal cohort study[SUP][1][/SUP].
The finding based on >2000 persons with serial CAC measurements in the Diabetes Prevention Program (DPP) and its DPP Outcomes Study (DPPOS), if backed up in appropriate clinical trials, suggests metformin might well be able to join other drugs given primarily for diabetes that also reduce the risk of cardiovascular disease.
http://www.medscape.com/viewarticle...t_card&uac=69617AV&spon=2&impID=1360147&faf=1
The finding based on >2000 persons with serial CAC measurements in the Diabetes Prevention Program (DPP) and its DPP Outcomes Study (DPPOS), if backed up in appropriate clinical trials, suggests metformin might well be able to join other drugs given primarily for diabetes that also reduce the risk of cardiovascular disease.
http://www.medscape.com/viewarticle...t_card&uac=69617AV&spon=2&impID=1360147&faf=1
